Likewise, IRS1 activation by inducing the PI3K-Akt signal transduction increases hepatic glucose uptake, glycogen synthesis, insulin sensitivity, and decreases lipogenesis, which in turn might ultimately attenuate NAFLD. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.